Venture funding rises in 2Q; NGM, Audentes and Lithera grab 3Q deals

Venture capital funding for US health care companies ramped up in the second quarter of 2013 after several quarters of decline compared to year-ago levels, and recent deals show significant venture dealmaking for biotechnology companies to kick off the third quarter of this year.